InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Raday Gilead. Officer active across 1 company, notably RedHill Biopharma Ltd.. In total, 2 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €3k. History available since 6 April 2026. The latest transaction was filed on 10 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条